AstraZeneca Names New CEO, Faces More Competition

Aug. 28 (Bloomberg) -- Bloomberg's Erik Schatzker reports that AstraZeneca named Pascal Soriot as chief executive officer as the company faces increased generic competition. He speaks on Bloomberg Television's "Market Makers." (Source: Bloomberg)
AXA CEO: Climate Change Is an Extremely Large Risk
54:07 - AXA Chief Executive Officer Henri De Castries discusses the risks associated with climate change for insurers and steps the company is taking to fight global warming. He speaks with Caroline Connan on Bloomberg Television’s “The Pulse.” (Source: Bloomberg)
  • Jaresko: $40 Billion Package Can Stabilize Ukraine
  • Euro-Area Growth Unlikely to Tail Off: Daly
  • Barclays Got Off Lightly With Fine: Bevan